Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis

Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership

(2013) Paul E. Stang et al.   ANNALS OF INTERNAL MEDICINE

Design considerations in an active medical product safety monitoring system

(2012) Joshua J. Gagne et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Detecting Drug Interactions From Adverse-Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose Levels

(2011) N P Tatonetti et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Can Network Analysis Improve Pattern Recognition Among Adverse Events Following Immunization Reported to VAERS?

(2011) R Ball et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data

(2011) Y Pouliot et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Commentary: What Can We Really Learn From Observational Studies?

(2011) David Madigan et al.   EPIDEMIOLOGY

Overcoming barriers to NLP for clinical text: the role of shared tasks and the need for additional creative solutions

(2011) Wendy W Chapman et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis

(2011) Santiago Vilar et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Using information mining of the medical literature to improve drug safety

(2011) Kanaka D Shetty et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

The National Center for Biomedical Ontology

(2011) Mark A Musen et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm

(2011) Paul Wicks et al.   NATURE BIOTECHNOLOGY

Safety surveillance of longitudinal databases: methodological considerations

(2011) G. Niklas Norén et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration

(2011) Amanda R. Patrick et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Predicting Adverse Drug Events Using Pharmacological Network Models

(2011) A. Cami et al.   Science Translational Medicine

Drug repurposing and adverse event prediction using high-throughput literature analysis

(2011) Spyros N. Deftereos et al.   Wiley Interdisciplinary Reviews-Systems Biology and Medicine

Post-Approval Drug Safety Surveillance

(2010) Robert D. Gibbons et al.   Annual Review of Public Health

Mining multi-item drug adverse effect associations in spontaneous reporting systems

(2010) Rave Harpaz et al.   BMC BIOINFORMATICS

Biclustering of Adverse Drug Events in the FDA's Spontaneous Reporting System

(2010) R Harpaz et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Confounding Control in Healthcare Database Research

(2010) M. Alan Brookhart et al.   MEDICAL CARE

Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project

(2010) Preciosa M. Coloma et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD

(2010) Martijn J. Schuemie   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

A basic study design for expedited safety signal evaluation based on electronic healthcare data

(2010) Sebastian Schneeweiss   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Data-Driven Methods to Discover Molecular Determinants of Serious Adverse Drug Events

(2009) AP Chiang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A Pharmacovigilance Program From Laboratory Signals for the Detection and Reporting of Serious Adverse Drug Reactions in Hospitalized Patients

(2009) E Ramirez et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Decision support methods for the detection of adverse events in post-marketing data

(2009) M. Hauben et al.   DRUG DISCOVERY TODAY

An Evaluation of Three Signal-Detection Algorithms Using a Highly Inclusive Reference Event Database

(2009) Alan M. Hochberg et al.   DRUG SAFETY

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

The New Sentinel Network — Improving the Evidence of Medical-Product Safety

(2009) Richard Platt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Managing Drug-Risk Information — What to Do with All Those New Numbers

(2009) Jerry Avorn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quantitative signal detection using spontaneous ADR reporting

(2009) A. Bate et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Pharmacogenomics of adverse drug reactions: practical applications and perspectives

(2009) Laurent Becquemont   PHARMACOGENOMICS

Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities

(2009) Edwin J. Matthews et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Prediction of drug-related cardiac adverse effects in humans-B: Use of QSAR programs for early detection of drug-induced cardiac toxicities

(2009) Anna A. Frid et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY